|
|
A precision medicine approach to identify walking phenotypes and rehabilitation targets after injury |
| 1R03TR004248-01 |
|
NCATS |
2022 |
|
|
MRI Biomarkers of Disease Progression in Inherited Neuropathies |
| 5R21TR003312-02 |
|
NCATS |
2022 |
|
|
Fiber design and assessment for development of a novel biomimetic medical device |
| 5R44TR001324-04 |
|
NCATS |
2022 |
|
|
Deconstructing interactions between diet, microbiome, and immunity to gain mechanistic insight into health and disease |
| 1K99AI159227-01A1 |
|
NIAID |
2022 |
|
|
Implant Biofilm Mediated Immune Response |
| 1R01AI165958-01A1 |
|
NIAID |
2022 |
|
|
Metabolic regulators of Treg/Th17 balance in CNS autoimmunity |
| 1R01AI169075-01A1 |
|
NIAID |
2022 |
|
|
Alu dsRNAs as adjuvants for influenza vaccines |
| 1R21AI164107-01A1 |
|
NIAID |
2022 |
|
|
Allograft inflammatory factor-1 and immune tolerance |
| 1R21AI171739-01 |
|
NIAID |
2022 |
|
|
Novel Biofilm Paradigm Explaining Clinical Implant-Associated Illness. |
| 1R21AI171932-01 |
|
NIAID |
2022 |
|
|
B cell-targeted CAR-T treatment of CNS Autoimmunity |
| 1R21AI171994-01 |
|
NIAID |
2022 |